Maggot excretions inhibit biofilm formation on biomaterials

Gwendolyn Cazander1, Mariëlle C van de Veerdonk, Christina M J E Vandenbroucke-Grauls

  • 1Department of Trauma Surgery, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, The Netherlands. G.Cazander@vumc.nl

Abstract

Insights

Maggot excretions/secretions effectively reduce bacterial biofilm formation on common biomaterials used in trauma surgery. This finding suggests a novel therapeutic approach for treating challenging biofilm infections associated with medical implants.

Area of Science:

  • Biomedical Engineering
  • Microbiology
  • Wound Healing

Background:

  • Biofilm-associated infections pose significant challenges in trauma surgery, often resisting conventional treatments.
  • Maggots are known to aid in healing infected wounds, particularly those suspected of biofilm formation.

Purpose of the Study:

  • To investigate the efficacy of maggot excretions/secretions in reducing biofilm formation by common bacterial pathogens on various surgical biomaterials.
  • To compare biofilm formation rates across different bacterial species and biomaterials over time.

Main Methods:

  • Bacterial species were incubated with comb-like biomaterial models in microtiter plates.
  • Biofilm formation was quantified using crystal violet staining and optical density measurements.
  • Maggot excretions/secretions were applied to established biofilms to assess their inhibitory effects.

Main Results:

  • Staphylococcus aureus and Staphylococcus epidermidis formed the strongest biofilms on polyethylene, while titanium showed the weakest biofilm formation.
  • Maximum biofilm formation occurred within 7 days for the tested bacteria.
  • Maggot excretions/secretions significantly reduced biofilm formation on all tested biomaterials, with up to 92% reduction observed.

Conclusions:

  • Maggot excretions/secretions demonstrate a potent ability to decrease bacterial biofilm formation on surgical biomaterials.
  • These findings suggest a promising new therapeutic strategy for managing biofilm infections in trauma and orthopedic surgery.